Wall Street Optimism Pushes J&J Toward $500 Billion Market Value

Johnson & Johnson reached a $500 billion stock market valuation on Wednesday as investors keep raising their bets that the firm’s strategy to cope with eroding sales for its major psoriasis drug will pan out.